Skip to content

Treatment of Sudden Deafness With Prednisone+Hyperbaric Oxygen and Prednisone+Somatosensory Stimulation

Prospective Study of Sudden Deafness

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04129983
Enrollment
60
Registered
2019-10-17
Start date
2020-06-30
Completion date
2020-10-31
Last updated
2020-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Loss, Sudden, Hyperbaric Oxygen, Prednisone Acetate, Somatic Stimulus

Keywords

Hearing Loss, Sudden, Prednisone acetate, Hyperbaric oxygen, Somatic stimulus

Brief summary

To study the effective treatment of sudden deafness by giving prednisone, hyperbaric oxygen and somatosensory stimulation to sudden deafness patients.

Detailed description

60 cases of sudden deafness within 2 months of 14-80 years old were randomly divided into two groups. They underwent hearing tests, magnetic resonance imaging of the head, and routine hospital admissions. One group was given prednisone for 1 mg / kg body weight × 7 days + somatosensory stimulation × 30 days, the other group was given prednisone for 1 mg / kg body weight × 7 days + hyperbaric oxygen × 15 days, and repeated electrical audiometry every week. One month and three months after the experiment, repeated audiometry.

Interventions

COMBINATION_PRODUCTDrugs and Stimulation

60 cases of sudden deafness were inquired about their medical history and examined by hearing and cranial magnetic resonance. They were randomly divided into two groups and given different treatments. The hearing test was repeated every 7 days. One month and three months after the treatment, the hearing examination was reexamined.

Sponsors

Dan Su
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
14 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Sudden deafness * History within 2 months * Age 14-80

Exclusion criteria

* Neurological diseases (such as brain tumors) * Patients with mental / mental illness undergoing treatment * Pregnant women and patients with other untreatable diseases * Finding the cause of sensorineural deafness * Patients Not Suitable for Hyperbaric Oxygen * A patient with dermatosis

Design outcomes

Primary

MeasureTime frameDescription
AudiometryThree months from the patient's selection to the end of treatmentEvaluate the patient's hearing to determine whether it has improved.
Cranial magnetic resonance imagingWhen patients are enrolledJudging whether the patient's inner ear has pathological changes or not

Countries

China

Contacts

Primary ContactDan Su, master
sudan19966991@outlook.com+8615755149100
Backup ContactBusheng Tong, doctor
2871638103@qq.com+8613956040273

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026